Hypokalemia Treatment

Definition & Severity Classification

Goals of Therapy

1. Prevent life-threatening and serious chronic consequences
2. Replace the associated K⁺ deficit
3. Correct the underlying cause and mitigate future hypokalemia

Step 1: Assess Urgency

• Prolonged QT interval
• Known cardiac disease
• Digoxin therapy (hypokalemia potentiates digoxin toxicity)
• Rapidly falling serum K⁺

Step 2: ECG Findings to Know

• Prominent U waves (most characteristic)
• T-wave flattening or inversion
• Prolonged QT/QU interval
• ST depression in severe cases
• Risk of ventricular arrhythmias (PVCs, VT, VF)

Step 3: Potassium Replacement

Oral Replacement (Preferred when tolerated)

• KCl (potassium chloride) — first-line for most cases, especially with concurrent metabolic alkalosis or chloride depletion
• Dose: 40–80 mEq/day in divided doses for mild-moderate hypokalemia
• Oral route is safer, has less rebound hyperkalemia risk
• Supplement with dietary sources (bananas, oranges, potatoes) as adjunct only

IV Replacement (For severe or symptomatic cases)

• Indication: K⁺ < 2.5 mEq/L, unable to tolerate oral, paralysis, life-threatening arrhythmia
• Rate: Typically ≤ 10–20 mEq/hour via peripheral IV; up to 40 mEq/hr via central line with continuous cardiac monitoring
• Concentration: ≤ 40 mEq/100 mL peripherally (higher concentrations cause phlebitis/pain)
• Caution: Risk of rebound hyperkalemia — recheck K⁺ after each 40 mEq replaced

Harrison's (p. 1432) specifically notes that urgent but cautious K⁺ replacement in severe redistributive hypokalemia (K⁺ < 2.5 mM) carries a risk of rebound hyperkalemia following resolution of the underlying cause.

Rule of Thumb for Deficit Estimation

• Every 1 mEq/L drop in serum K⁺ ≈ 200–400 mEq total body deficit
• This is a rough estimate; serial monitoring is essential

Step 4: Correct Concurrent Magnesium Deficiency

• Hypomagnesemia is a common cause of refractory hypokalemia — magnesium is required for renal K⁺ conservation
• Always check Mg²⁺; if low, replete first (IV MgSO₄ 1–2 g or oral magnesium oxide)
• Hypokalemia will not correct until Mg²⁺ is normalized

Step 5: Treat Underlying Cause

Harrison's (p. 1432) notes that when excess sympathetic activity drives redistributive hypokalemia (as in TPP), non-selective beta-blockade is the preferred intervention.

Special Populations & Cautions

• Digoxin users: Treat even mild hypokalemia aggressively — K⁺ < 3.5 mEq/L increases digoxin toxicity risk
• Diabetic ketoacidosis (DKA): Start K⁺ replacement before insulin if K⁺ < 3.5 mEq/L; insulin will drive K⁺ further into cells
• Renal insufficiency: Use slower, more cautious replacement — reduced urinary K⁺ excretion increases hyperkalemia risk
• Redistributive hypokalemia (e.g., insulin excess, alkalosis, beta-agonists): Treat underlying cause first; aggressive K⁺ infusion may cause rebound hyperkalemia

Monitoring

• Recheck serum K⁺ after every 40–60 mEq replaced (IV) or daily (oral)
• Monitor ECG continuously in severe cases
• Check K⁺, Mg²⁺, and acid-base status together
• Urine K⁺ (spot urine K⁺/Cr ratio or TTKG) helps distinguish renal vs. extrarenal losses if etiology is unclear

Summary Algorithm

Serum K⁺ < 3.5 mEq/L
        ↓
Check ECG + Mg²⁺ + acid-base
        ↓
K⁺ ≥ 3.0 + asymptomatic → Oral KCl 40–80 mEq/day
K⁺ 2.5–3.0 or symptomatic → Oral + consider IV
K⁺ < 2.5 or arrhythmia → IV replacement + telemetry
        ↓
Correct Mg²⁺ deficiency if present
        ↓
Identify and treat underlying cause
        ↓
Serial K⁺ monitoring until stable